Aptus Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE15XJ01010
  • NSEID:
  • BSEID: 544529
INR
349.30
6.75 (1.97%)
BSENSE

Mar 25

BSE+NSE Vol: 2000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.0 k (-37.50%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.89%

Why is Aptus Pharma Ltd falling/rising?

17-Mar-2026

As of 16-Mar, Aptus Pharma Ltd's stock price is rising to Rs. 346.70, reflecting a 5.0% increase. The stock has significantly outperformed the Sensex over various periods, indicating strong investor confidence and a positive upward trend.

As of 16-Mar, Aptus Pharma Ltd's stock price is rising, currently at Rs. 346.70, reflecting a change of Rs. 16.5 or 5.0%. This increase can be attributed to several factors. Over the past week, the stock has gained 21.52%, significantly outperforming the Sensex, which has declined by 2.66% during the same period. Additionally, the stock has shown remarkable performance over the last month with a rise of 40.68%, while the Sensex has decreased by 9.34%. Year-to-date, Aptus Pharma has surged by 104.54%, contrasting with the Sensex's decline of 11.40%.<BR><BR>Today, the stock reached a new 52-week and all-time high of Rs. 346.7, indicating strong investor confidence. The stock has been on a consecutive gain streak for the last four days, contributing to its recent performance. Furthermore, the stock outperformed its sector by 6.12% today. Increased investor participation is also evident, with a delivery volume increase of 104.55% against the 5-day average noted on March 13. <BR><BR>The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive technical indicator. Despite some erratic trading patterns, including not trading on one day out of the last 20, the overall sentiment and performance metrics suggest a strong upward trend for Aptus Pharma Ltd.

View full answer

Which are the latest news on Aptus Pharma?

25-Mar-2026
No latest news for Aptus Pharma found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 235 Cr (Micro Cap)

stock-summary
P/E

81.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

13.64%

stock-summary
Price to Book

10.83

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
116.96%
0%
116.96%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Aptus Pharma for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting Held On March 24 2026

24-Mar-2026 | Source : BSE

Outcome of Board Meeting held on March 24 2026

Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Tuesday March 24 2026

17-Mar-2026 | Source : BSE

Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve This is to inform you that meeting of the Board of Directors of the Company will be held on Tuesday March 24 2026 at Shri 1st Floor Opp Satyasai Heart Hospital Narayan Nagar Kalawad Road Kankot Rajkot Gujarat India 360005 to consider inter alia a proposal for: 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Consideration and recommendation of Bonus Equity Shares subject to approval of Members of the Company. Trading Window for dealing in the securities of the Company for all the Designated Persons and their immediate relatives will remain closed with effect from Wednesday 18th March 2026 Thursday March 26 2026 (both days inclusive) for aforesaid consideration/recommendation of the Board of Directors of the Company.

Closure of Trading Window

17-Mar-2026 | Source : BSE

With Reference to the above mentioned subject it is hereby informed that the trading window for dealing in shares of Aptus Pharma Limited for all designated persons will remain closed from Wednesday March 18 2026 to Thursday March 26 2026 (both days inclusive) for the purpose of 1. Increase in Authorized Share Capital subject to the approval of Members and 2. Consideration and recommendation of Bonus issue of equity shares subject to aproval of Members.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.91
Debt to EBITDA (avg)
1.71
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.82
Tax Ratio
27.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.87%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
81
Industry P/E
32
Price to Book Value
11.04
EV to EBIT
52.00
EV to EBITDA
49.15
EV to Capital Employed
15.01
EV to Sales
9.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
28.87%
ROE (Latest)
13.64%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bearish
Bollinger Bands
Bullish
KST
Dow Theory
No Trend
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Kapilbhai Hasmukhbhai Chandarana (11.3%)

Highest Public shareholder

Saint Capital Fund (4.29%)

Individual Investors Holdings

22.97%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aptus Pharma"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Aptus Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Aptus Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Aptus Pharma"
  }
]
stock-summaryCompany CV
About Aptus Pharma Ltd stock-summary
stock-summary
Aptus Pharma Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available